Hypoglycaemia.
The DOI matches its Crossref record; 122 of the 122 references it cites were found in a registry or an index.
Abstract
In health hypoglycaemia is rare and occurs only in circumstances like extreme sports. Hypoglycaemia in type 1 Diabetes (T1D) and advanced type 2 Diabetes (T2D) are the result of interplay between absolute or relative insulin access and defective glucose counterregulation. The basic mechanism is, failure of decreasing insulin and failure of the compensatory increasing counterregulatory hormones at the background of falling blood glucose. Any person with Diabetes on anti-diabetic medication who behaves oddly in any way whatsoever is hypoglycaemic until proven otherwise. Hypoglycaemia can be a terrifying experience for a patient with Diabetes. By definition, hypoglycaemic symptoms are subjective and vary from person to person and even episode to episode in same person. Fear of iatrogenic hypoglycaemia is a major barrier in achieving optimum glycaemic control and quality of life which limits the reduction of diabetic complications. Diabetes patients with comorbidities especially with chronic renal failure, hepatic dysfunction, major limb amputation, terminal illness, cognitive dysfunction etc. are more vulnerable to hypoglycaemia. In most cases, prompt glucose intake reverts hypoglycaemia. Exogenous insulin in T1D and insulin treated advanced T2D have no control by pancreatic regulation. Moreover, failure of increase of glucagon and attenuated secretion in epinephrine causes the defective glucose counterregulation. In this comprehensive review, I will try to touch all related top…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Severe hypoglycemia and risks of vascular events and death
Zoungas, S., Patel, A., Chalmers, J., de Galan, B. E., Li, Q., Billot, L., Woodward, M., Ninomiya, T., Neal, B., MacMahon, S., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1003795 · Cited by 1,471
Seaquist, E. R., Anderson, J., Childs, B., Cryer, P., Dagogo-Jack, S., Fish, L., Heller, S. R., Rodriguez, H., Rosenzweig, J., & Vigersky, R. (2013) · Diabetes Care · doi:10.2337/dc12-2480 · Cited by 1,389
Cryer, P. E., Axelrod, L., Grossman, A. B., Heller, S. R., Montori, V. M., Seaquist, E. R., & Service, F. J. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1410 · Cited by 1,277
Hypoglycemia and risk of death in critically ill patients
The NICE-SUGAR Study Investigators (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1204942 · Cited by 1,009
Davidson's Principles and Practice of Medicine.
(1985) · Annals of Internal Medicine · doi:10.7326/0003-4819-103-6-973_2 · Cited by 936
Bonds, D. E., Miller, M. E., Bergenstal, R. M., Buse, J. B., Byington, R. P., Cutler, J. A., Dudl, R. J., Ismail-Beigi, F., Kimel, A. R., Hoogwerf, B., et al. (2010) · BMJ · doi:10.1136/bmj.b4909 · Cited by 933
Risk of hypoglycaemia in types 1 and 2 diabetes: Effects of treatment modalities and their duration
UK Hypoglycaemia Study Group (2007) · Diabetologia · doi:10.1007/s00125-007-0599-y · Cited by 825
Research works printed but not linked: 6
- Cryer PE, Axelrod L, Grossman AB et al (2009b) Evaluation and management of adult hypoglycemic disorders: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 94:709–728 · DOI · Paper page
- Driving and Vehicle Licencing Authority (2019) Drivers who have any form of diabetes treated with any insulin preparation must inform DVLA, pp 1–5
- Heller SR (2016) Glucose concentrations of less than 3.0 Mmol/L (54 Mg/DL) should be reported in clinical trials: a joint position statement of the American Diabetes Association and the European Association for the Study of Diabetes: Table 1. Diabetes Care 40(1):155–157
- Heller SR et al (2020b) Redefining hypoglycemia in clinical trials: validation of definitions recently adopted by the American Diabetes Association/European Association for the study of diabetes. Diabetes Care 43(2):398–404 · DOI
- International Diabetes Federation (2011) Chapter 11: Global IDF/ISPAD guideline for diabetes in childhood and adolescence. International Diabetes Federation, Brussels
- The Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977–986 · DOI · Paper page
Cited by
Current and future therapies to treat impaired awareness of hypoglycemia
Macon, E. L., DEVORE, M. H., Lin, Y. K., MUSIC, M. B., WOOTEN, M., McMullen, C. A., Woodcox, A. M., MARKSBURY, A. R., Beckner, Z., Patel, B. V., et al. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1271814 · Cited by 23
“Thus, people with recurrent episodes of insulin-induced hypoglycemia have a diminished ability to detect hunger, sweating, tremors, or other signals that indicate that carbohydrates should be ingested to raise blood glucose levels (Cryer, 1993; Davis et al., 2000; Muneer, 2021).”
BackgroundInfluentialLin, S., Ouyang, Y., Lin, W., Zhou, X., Miao, M., Cheng, E., Jiang, Y. H., Meng, Z., Jin, M., Zhang, S., et al. (2024) · Surfaces and Interfaces · doi:10.1016/j.surfin.2024.103847 · Cited by 27
Huang, J., Peng, W., Ding, S., Xiong, S., & Liu, Z. (2022) · Scientific Reports · doi:10.1038/s41598-022-24822-1 · Cited by 22
Validity of mental and physical stress models
Hendry, E., McCallister, B., Elman, D. J., Freeman, R. L., Borsook, D., & Elman, I. (2024) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2024.105566 · Cited by 19
Li, C., Ma, Y., Chai, X., Feng, X. M., Feng, W., Zhao, Y., Cui, C., Wang, J., Zhao, S., & Zhu, X. (2023) · Food & Function · doi:10.1039/d3fo04007k · Cited by 16
Wu, C., Wang, W., Cheng, S., Zhang, H., Li, L., Tian, C., Zhang, L., Chen, N., Du, J., Ren, L., et al. (2023) · BMC Psychiatry · doi:10.1186/s12888-023-04698-9 · Cited by 17
Insulin murder and the case of Colin Norris
Jones, A. W. (2023) · Journal of Forensic and Legal Medicine · doi:10.1016/j.jflm.2023.102483 · Cited by 13
Jin, F., Wang, Y., Li, M., Li, R.-J., & Guo, J. (2024) · World Journal of Diabetes · doi:10.4239/wjd.v15.i8.1764 · Cited by 11
Nanocarriers and Diabetes: New Vistas and the Way Ahead
Mishra, D. K., Gautam, R. K., Dixit, P. V., & Sharma, S. (2022) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201024666221227140728 · Cited by 9
Diabetes: from Research to Clinical Practice
(2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-51089-3 · Cited by 6
He, B., Fan, L., Deng, C., Liu, F., Xie, Y., Zhou, Z., & Li, X. (2024) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002983 · Cited by 5
Xie, L. F., Housni, A., Roy‐Fleming, A., Bandini, A., Delormier, T., Costa, D. D., & Brazeau, A. (2023) · Digital Health · doi:10.1177/20552076231204435 · Cited by 10
“7 Therefore, for PWT1D, diabetes self-management education and support (DSME/S) are essential.”
BackgroundFerhatbegović, L., Bećirović, M., Bečirović, E., Sarajlić, S., Ribić, A., Šarić, A., Bećirović, A., & Pojskić, B. (2026) · Frontiers in Clinical Diabetes and Healthcare · doi:10.3389/fcdhc.2026.1765597 · Cited by 5
“Repeated episodes of hypoglycemia can diminish the typical autonomic sympathoadrenal responses to decreasing glucose levels, leading to reduced awareness of hypoglycemia and impaired glucose counter-regulation, a condition known as hypoglycemia-associated autonomic failure (HAAF) (13, 18, 19).”
InfluentialBody condition of stranded Razorbills and Atlantic Puffins in the Western Mediterranean
Trapletti‐Lanti, Y., Expósito‐Granados, M., López‐Martínez, S., Torres-Rodríguez, M., & Rivas, M. L. (2024) · Ecology and Evolution · doi:10.1002/ece3.70161 · Cited by 4
“The metabolite values found in the tissues of sampled birds are consist - ent with a state of fatigue that could result from the development of hypoglycaemia (Muneer, 2021 ) or depletion of muscle glycogen (Braun & Sweazea, 2008).”
BackgroundHe, B., Liu, Z.-Z., Xu, R.-Y., Li, F., Guo, R., Deng, C., Xie, Y., Zhou, Z., & Li, X. (2025) · World Journal of Diabetes · doi:10.4239/wjd.v16.i6.104024 · Cited by 6
Lü, P., Cui, L., Wang, Y., Kang, K., Gu, H., Li, Z., Liu, L., Wang, Y., & Zhao, X. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.648907 · Cited by 3
Li, M., Jin, F., Zhao, J., Wang, Y., Zhuang, B., & Li, R.-J. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16409 · Cited by 3
Li, Y., Wang, Y. H., Zhang, J., Zhang, R., Yao, Z., Chen, X., & Xu, X. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1702197 · Cited by 2
Role of intestinal glucagon-like peptide-1 in impaired counter-regulatory responses to hypoglycemia
Dodamani, M. H., Hatwal, J., & Batta, A. (2024) · World Journal of Diabetes · doi:10.4239/wjd.v15.i12.2394 · Cited by 2
Medical perspectives on pediatric sports medicine–Selective topics
Cabral, M. D., Patel, D. R., Greydanus, D. E., Deleon, J., Hudson, E., & Darweesh, S. (2022) · Disease-a-Month · doi:10.1016/j.disamonth.2022.101327 · Cited by 8
Wanyan, X., Lin, M., Tian, J., & Lin, Y. Y. (2026) · Frontiers in Physiology · doi:10.3389/fphys.2026.1824651 · Cited by 1
“Variables with P 0.1 in univariate analysis were included in Firth penalized logistic regression to identify independent risk factors for hypoglycemia (correcting for rare-event bias) (Muneer, 2021).”
InfluentialHaba, T., Yamakawa, K., Ozeki, S., Sumida, A., Kato, T., Kuroda, E., Maruyama, T., Murakami, T., & Yabe, D. (2024) · Diabetology International · doi:10.1007/s13340-024-00722-9 · Cited by 2
“Neurogenic symptoms of hypoglycemia such as sweating, tremors, palpitations and anxiety usually precede neuroglycopenic symptoms such as cognitive impairment, mood and behavioral changes, blurred vision, seizure and coma [4].”
Mitochondria-Associated Membranes Are Not Altered In Immune Cells In T2DPreprint
Hart, S. N., Lenin, R. R., Sturgill, J., Kern, P. A., & Nikolajczyk, B. S. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.03.25.586170 · Cited by 2
“Although T2D is characterized by hyperglycemia, hyperlipidemia, hyperinsulinemia, and a host of additional physiological changes, we focused on hyperglycemia as the clinically relevant indicator for T2D and mediator of T2D-associated inflammation [26, 37].”
BackgroundIntestinal glucagon-like peptide-1 in hypoglycemic counterregulation for type 1 diabetes management
Zhang, K., Kan, C., Wang, Y.-Q., Hou, N., & Sun, X. (2024) · World Journal of Diabetes · doi:10.4239/wjd.v15.i12.2380 · Cited by 1
INFLUENCE OF THE STATISTICAL PROPERTIES OF THE IONOSPHERE ON RADIO WAVE ABSORPTION MEASUREMENTS.
Gorshkova, V. E. (1967) · OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information)
Dasiglucagon for treating severe hypoglycemia in patients with diabetes
Ju, Y., Zhang, D., & Yang, J. (2022) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2022.2103537
Fasting versus Nonfasting for Cardiac Interventions: A Systematic Review and Meta-Analysis
Dawadi, S., Shrestha, D. B., Oli, P. R., Shtembari, J., Pant, K. C., & Meghani, M. (2026) · Journal of Clinical and Preventive Cardiology · doi:10.4103/jcpc.jcpc_41_25
Hussien, R. M., El‐Ashry, A. M., AlFaris, N. A., & Hendy, A. (2026) · Healthcare · doi:10.3390/healthcare14142171 · Cited by 1
“However, FOH represents a significant barrier to blood sugar control, potentially causing or worsening complications in patients and adversely affecting diabetes management [27].”
Metadata
- Authors
- Muneer, M.
- Affiliations
- Cardiff University (GB)
- Corresponding author
- Muneer, Muhammad
- ORCID
- Muneer, Muhammad
- Venue
- Advances in Experimental Medicine and Biology
- Publisher
- Springer International Publishing
- Published
- 2020
- Volume
- 1307
- Pages
- 43-69
- ISSN
- 0065-2598 (ISSN-L)
- 2214-8019
- OpenAlex
- W4205143314
- Cited by
- 28
- References
- 119
- Citations by year
- 2026: 4 · 2025: 3 · 2024: 9 · 2023: 5 · 2022: 4 · 2021: 1 · 2020: 1
- FWCI
- 12.55
- Type
- book chapter
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Advances in experimental medicine and biology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Keywords
- hypoglycemia, type 1 diabetes, type 2 diabetes, glucose counterregulation, insulin, glucagon, epinephrine, antidiabetic drugs, comorbidities, glycemic control, quality of life
- MeSH terms
- Blood Glucose, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Humans, Hypoglycemia, Insulin, Quality of Life, Comorbidity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.